Search alternatives:
significant advances » significant advantages (Expand Search), significantly advanced (Expand Search), significant advancements (Expand Search)
advances decrease » advanced disease (Expand Search), advanced defense (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 41 - 60 results of 1,669 for search '(( significant advances decrease ) OR ( significant ((side decrease) OR (nn decrease)) ))', query time: 0.53s Refine Results
  1. 41
    Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease.docx

    Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

    Published 2025
    Save to List
    Saved in:
  2. 42
    Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver disease.xlsx

    Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

    Published 2025
    Save to List
    Saved in:
  3. 43
    lncCyt b cooperates with hnRNPA2B1 to modulate glycolysis and exhibits physiological significance.

    lncCyt b cooperates with hnRNPA2B1 to modulate glycolysis and exhibits physiological significance. by Jia Li (160557)

    Published 2025
    Save to List
    Saved in:
  4. 44
    Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescriptions).

    Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 45
    Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n = 269.151prescriptions).

    Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 46
    Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019.

    Shares of specialist groups prescribing 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 47
    Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0).

    Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 48
    Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.814 prescriptions; urologists n = 182.100 prescriptions).

    Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 49
    Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription.

    Comparison of 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> antibiotic prescription. by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 50
    UTI diagnoses by sex and physician specialty (2013–2019).

    UTI diagnoses by sex and physician specialty (2013–2019). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 51
    Percent Decrease in FGM between Oldest (45-49 years) and Youngest (15-19 years) Cohorts of Women over the years in Egypt.

    Percent Decrease in FGM between Oldest (45-49 years) and Youngest (15-19 years) Cohorts of Women over the years in Egypt. by Shatha Elnakib (8901764)

    Published 2025
    Save to List
    Saved in:
  12. 52
    Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT.

    Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT. by Renáta Kiss-Miki (20760127)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 53
    (A) Side image of epoxy resin-made abutment-analog base and prosthesis; (B) Front image of epoxy resin-made abutment-analog base and prosthesis.

    (A) Side image of epoxy resin-made abutment-analog base and prosthesis; (B) Front image of epoxy resin-made abutment-analog base and prosthesis. by Long Li (6555)

    Published 2025
    Save to List
    Saved in:
  14. 54
    Everolimus decreased CD89 deposits in α1<sup>KI</sup>CD89<sup>Tg</sup> mice.

    Everolimus decreased CD89 deposits in α1<sup>KI</sup>CD89<sup>Tg</sup> mice. by Alexandra Cambier (22307216)

    Published 2025
    Save to List
    Saved in:
  15. 55
    Expression pattern of statistically significantly differentially expressed immune-related genes in CL patients compared to healthy volunteers.

    Expression pattern of statistically significantly differentially expressed immune-related genes in CL patients compared to healthy volunteers. by Nasrin Masoudzadeh (20300511)

    Published 2025
    Save to List
    Saved in:
  16. 56
    Fig 1 -

    Fig 1 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 57
    Fig 8 -

    Fig 8 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells.

    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 59
    Fig 4 -

    Fig 4 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    Fig 9 -

    Fig 9 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: